Cargando…
Metformin as an Adjuvant to Photodynamic Therapy in Resistant Basal Cell Carcinoma Cells
Photodynamic Therapy (PDT) with methyl-aminolevulinate (MAL-PDT) is being used for the treatment of Basal Cell Carcinoma (BCC), although resistant cells may appear. Normal differentiated cells depend primarily on mitochondrial oxidative phosphorylation (OXPHOS) to generate energy, but cancer cells s...
Autores principales: | Mascaraque, Marta, Delgado-Wicke, Pablo, Nuevo-Tapioles, Cristina, Gracia-Cazaña, Tamara, Abarca-Lachen, Edgar, González, Salvador, Cuezva, José M., Gilaberte, Yolanda, Juarranz, Ángeles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139992/ https://www.ncbi.nlm.nih.gov/pubmed/32183017 http://dx.doi.org/10.3390/cancers12030668 |
Ejemplares similares
-
Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy
por: Gracia-Cazaña, Tamara, et al.
Publicado: (2019) -
Metformin overcomes metabolic reprogramming-induced resistance of skin squamous cell carcinoma to photodynamic therapy
por: Mascaraque-Checa, Marta, et al.
Publicado: (2022) -
Combined Treatments with Photodynamic Therapy for Non-Melanoma Skin Cancer
por: Lucena, Silvia Rocío, et al.
Publicado: (2015) -
Potent Virucidal Activity In Vitro of Photodynamic Therapy with Hypericum Extract as Photosensitizer and White Light against Human Coronavirus HCoV-229E
por: Praena, Beatriz, et al.
Publicado: (2022) -
Tumor microenvironment in non-melanoma skin cancer resistance to photodynamic therapy
por: Cerro, Paulina A., et al.
Publicado: (2022)